Blog
Welcome to the Evidence Hub
At Aetion, we work at the crossroads of health care: the point at which patients, ...
Blog
Framework for FDA’s Real-World Evidence Program: Dr. Sebastian Schneeweiss considers implications for biopharma
In December 2018, the U.S. Food and Drug Administration unveiled its strategy to assess ...
Blog
Leading change at Pfizer: A conversation with Chris Boone
As costs soar and patients wait, forward-looking pharmaceutical companies are exploring ...
Blog
Four questions to ask your data
A vital step in generating real-world evidence is understanding where the available data ...
Blog
A year of acceleration: Looking ahead at 2019
The place where two rivers meet is called a confluence—a good word for the year ahead in ...